Promethera Biosciences SA, a Mont Saint Guibert, Belgium- and Durham, NC, USA-based innovator in cell-based medicines and liver diseases, raised €9.3mi (approx. $11.5m) through the issuance of convertible bonds.
UgenTec, a Hasselt, Belgium-based medical technology company that has developed an AI-driven polymerase chain reaction (PCR) analysis and workflow software, closed a $9.3m (€7.5m) funding round.
Cubigo, a Hasselt, Belgium-based developer of a platform for the senior living industry, raised $4.5m in Series A venture capital funding.
PieSync, a Ghent, Belgium-based cloud application to manage contact information company, raised €2.8m ($3.5m) in funding.
Minakem, a contract manufacturing company, specialized in custom development and manufacturing of building blocks, intermediates and Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry, received a €14.5M ($18M) investment from parent company Minafin.
BCI Pharma, a Liège, Belgium-based biotechnology company developing innovative kinase inhibitor libraries, received €3.9m in funding.
Mars Petcare, a Brussels, Belgium-based pet nutrition and health care business, has launched two new programs to support startup innovation in the pet care industry.
Convert Pharmaceuticals, a Liège, Belgium-based developer of tumor-microenvironment modulated prodrugs, received a €13.6m in equity and non-dilutive funding.
Synergia Medical SA, a Mont-Saint-Guibert, Belgium-based opto-electronics developer advancing medical devices for neurostimulation, raised €8.1m in Series A funding.
Syndesi Therapeutics, a Belgian developer of a series of novel, procognitive SV2A modulators, raised €17M in Series A financing.
Showpad, a Ghent, Belgium- and Chicago, IL-based sales and marketing success platform, secured $25m in additional Series C funding.
LindaCare, a Leuven, Belgium, and Hartford, CT-based digital health company specializing in remote patient monitoring solutions for chronic disease management, raised $7m in Series B funding.
VitriCell SA, a Liège, Belgium-based biotech company providing solutions for cryopreservation of even the most sensitive cells, closed a €1m ($1.2M) Series A round of funding.
Univercells, a Gosselies, Belgium based technology company dedicated to delivering innovative and cost-effective biomanufacturing solutions, has received a €2.4M grant.
MobileXpense, a Brussels, Belgium-based software company specialized in travel and expense management, raised €20m in funding.